Skin lesions in chronic lymphocytic leukemia

References

• Redaelli A, Laskin B L, Stephens J M, Botteman M F, Paschos C L. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care 2004; 13: 279–287
   PubMed Web of Science ®Google Scholar
• Kalil N, Cheson B D. Management of chronic lymphocytic leukaemia. Drugs Aging 2000; 16: 9–27
   PubMed Web of Science ®Google Scholar
• Robak T. Therapy of chronic lymphocytic leukemia: facts and controversies. Drugs Aging 2005; 22: 983–1012
   PubMed Web of Science ®Google Scholar
• Ries L AG, Eisner M P, Kosary C L, Hankey B F, Miller B A, Clegg L. Editors SEER Cancer Statistic Review 1975 – 2001. National Cancer Institute (online), Bethesda, MD, Available from URL http://Seer.cancer.gov/csr/1975_2000.2003. Accessed November 8, 2005
   Google Scholar
• Dighiero G, Binet J L. When and how to treat chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1799–1801
   PubMed Web of Science ®Google Scholar
• Cerroni L, Zenahlik P, Hofler G, Kaddu S, Smolle J, Kerl H. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia. A clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 1996; 20: 1000–1010
   PubMed Web of Science ®Google Scholar
• Greenwood R, Barker D J, Tring F C, Parapia L, Reid M, Scott C. Clinical and immunohistological characterization of cutaneous lesions in chronic lymphocytic leukaemia. Br J Dermatol 1985; 113: 447–453
   PubMed Web of Science ®Google Scholar
• Agnew K L, Ruchlemer R, Catovsky D, Matutes E, Bunker C B. Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol 2004; 150: 1129–1135
   PubMed Web of Science ®Google Scholar
• Robak E, Robak T, Biernat W, Bartkowiak J, Krykowski E. Successful treatment of leukaemia cutis with cladribinein a patient with B-cell chronic lymphocytic leukemia. Br J Dermatol 2002; 147: 775–780
   PubMed Web of Science ®Google Scholar
• Colburn D E, Welch M A, Giles F J. Skin infiltration with chronic lymphocytic leukemia is consistent with a good prognosis. Hematology 2002; 7: 187–188
   PubMedGoogle Scholar
• Cabuk M, Inanir I, Turkdogan P, Ceylan C, Degirmenci M, Turel A, et al. Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia. Leuk Lymphoma 2004; 45: 811–813
   PubMed Web of Science ®Google Scholar
• Desch J K, Smoller B R. The spectrum of cutaneous disease in leukemia. J Cutan Pathol 1993; 20: 407–410
   PubMed Web of Science ®Google Scholar
• Bonvalet D, Foldes C, Civatte J. Cutaneous manifestations in chronic lymphocytic leukemia. J Dermatol Surg Oncol 1984; 10: 278–282
   PubMedGoogle Scholar
• Ratnam K V, Kohr C J, Su W P. Leukemia cutis. Dermatol Clin 1994; 12: 419–431
   PubMed Web of Science ®Google Scholar
• Paydas S, Zorludemir S. Leukaemia cutis and leukaemic vasculitis. Br J Dermatol 2000; 143: 773–779
   PubMed Web of Science ®Google Scholar
• Hallek M. New concepts in the pathogenesis, diagnosis, prognostic factors and clinical presentation of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000; 4: 103–117
   Google Scholar
• Su W P. Clinical, histopthologic and immunohistochemical correlations in leukemia cutis. Semin Dermatol 1994; 13: 223–230
   PubMedGoogle Scholar
• Fayolle J, Coeur P, Bryon P A, Gentilhomme O, Moulin G, Morel P. Cutaneous manifestations of chronic lymphoid leukemia: a propos of 44 cases from a personal series of 430 cases of chronic lymphoid leukemia. Ann Dermatol Syphiligr 1973; 005-24: 5–24
   Google Scholar
• High D A, Luscombe H A, Kauh Y C. Leukemia cutis masquerading as chronic paronychia. Int J Dermatol 1985; 24: 595–597
   PubMed Web of Science ®Google Scholar
• Ausubel H, Levine M L, Shapiro L. Leukemia cutis manuum. NY State J Med 1970; 70: 2835–2837
   PubMedGoogle Scholar
• Rosen L B, Frank B L, Rywlin A M. A characteristic vesiculobullous eruption in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 1986; 15: 943–950
   PubMed Web of Science ®Google Scholar
• Davis M D, Perniciaro C, Dahl P R, Randle H W, McEvoy M T, Leiferman K M. Exaggerated arthropod-bite lesions in patients with chronic lymphocytic leukemia: a clinical, histopathologic, and immunopathologic study of eight patients. J Am Acad Dermatol 1998; 39: 27–35
   PubMed Web of Science ®Google Scholar
• Simon C A, Su W P, Li C Y. Subungual leukemia cuttis. Int J Dermatol 1990; 29: 636–639
   PubMed Web of Science ®Google Scholar
• Zimmer M, Bornkessel A, Hahnfeld S, Weyers W. “Specific” cutaneous infiltrate of B-cell chronic lymphocytic leukemia at the site of a florid herpes simplex infection. J Cutan Pathol 2005; 32: 581–584
   PubMed Web of Science ®Google Scholar
• Aberer W, Zonzits E, Soyer H P, Kerl H. Post-zoster-specific skin infiltrates in chronic lymphatic leukemia. Hautarzt 1990; 41: 455–457
   PubMed Web of Science ®Google Scholar
• Smoller B R, Warnke R A. Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to primary cutaneous epithelial neoplasms. J Cutan Pathol 1998; 25: 160–164
   PubMed Web of Science ®Google Scholar
• Dargent J L, Kornreich A, Andre L, Lespagnard L. Cutaneous infiltrate of chroic lymphocytic leukemia surrounding a primary squamous cell carcinoma of the skin: report of an additional case and reflection on its pathogenesis. J Cutan Pathol 1998; 25: 479–480
   PubMed Web of Science ®Google Scholar
• Buechner S A, Li C Y, Su W P. Leukemia cutis: a histopathologic study of 42 cases. Am J Dermatopathol 1985; 7: 109–119
   PubMed Web of Science ®Google Scholar
• Cerroni L, Hofler G, Back B, Wolf P, Maier G, Kerl H. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia (B-CLL) at sites typical for Borrelia burgdoferi infection. J Cutan Pathol 2002; 29: 142–147
   PubMed Web of Science ®Google Scholar
• Varkonyi J, Zalatnai A, Timar J, Matolocsi A, Falus A, Benesath M, et al. Secondary cutaneous infiltration in B-cell chronic lymphocytic leukemia. Acta Haematol 2000; 103: 116–121
   PubMed Web of Science ®Google Scholar
• Jasim Z F, Cooke N, Somerville J E, Hay R J. Chronic lymphocytic leukaemia skin infiltrates affecting prominent parts of the face and the scalp. Br J Dermatol 2006; 154: 981–982
   PubMed Web of Science ®Google Scholar
• Kazakov D V, Belousova I E, Michaelis S, Palmedo G, Samtsor A V, Kempf W. Unusual manifestations of specific cutaneous involvement by B-cell chronic lymphocytic leukemia: spontaneous regression with scar formation. Dermatology 2003; 207: 111–115
   PubMed Web of Science ®Google Scholar
• Robak T, Kasznicki M. Alkylating agents and nucleoside analogues in the treatment of B-cell chronic lymphocytic leukemia. Leukemia 2002; 16: 1015–1027
   PubMed Web of Science ®Google Scholar
• Spaner D E, Miller R L, Mena J, Grossman L, Sorrenti V, Shi Y. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Leuk Lymphoma 2005; 46: 935–939
   PubMed Web of Science ®Google Scholar
• Porter W M, Sidwell R U, Catovsky D, Bunker C B. Cutaneous presentation of chronic lymphatic leukaemia and response to ultraviolet B phototherapy. Br J Dermatol 2001; 144: 1092–1094
   PubMed Web of Science ®Google Scholar
• Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology 2004; 9: 387–400
   PubMedGoogle Scholar
• Robak T, Bloński J Z, Góra-Tybor J, et al. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia treated with cladribine. Eur J Cancer 2004; 40: 383–389
   PubMed Web of Science ®Google Scholar
• Ratnavel R C, Dunn-Walters D K, Boursier I, Frazer-Andrews E, Orchard G, Russel-Jones R, et al. B-cell lymphoma associated with chronic lymphatic leukaemia: two cases with contrasting aggressive and indolent behaviour. Br J Dermatol 1999; 140: 708–714
   PubMed Web of Science ®Google Scholar
• Zarco C, Lahureta-Palacios J J, Borrego L, Toscano R, Gil R, Iglesias L. Centroblastic transformation of chronic lymphocytic leukaemia with primary skin involvement—cutaneous presentation of Richter's syndrome. Clin Exp Dermatol 1993; 18: 263–267
   PubMed Web of Science ®Google Scholar
• Robak E, Góra-Tybor J, Kordek R, Wawrzyniak E, Bartkowiak J, Bednarek A. Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukemia. Br J Dermatol 2005; 153: 833–837
   PubMed Web of Science ®Google Scholar
• Robertson L E, Pough W, O'Brien S, Kantarjian H, Hirsch-Ginsberg C, Cork A. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985–1989
   PubMed Web of Science ®Google Scholar
• Manusow D, Weinerman B H. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975; 223: 267–269
   Google Scholar
• Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma 2004; 46: 49–54
   Web of Science ®Google Scholar
• Weimar V M, Ceilley R I, Goeken J A. Aggressive biologic behavior of basal- and squamous-cell cancer in patients with chronic lymphocytic leukemia or lymphocytic lymphoma. J Dermatol Surg Oncol 1979; 5: 609–614
   PubMedGoogle Scholar
• Frierson H F, Jr, Deutsch B D, Levine P A. Clinicopathologic features of cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988; 19: 1397–1402
   PubMed Web of Science ®Google Scholar
• Travis L B, Curtis R E, Hankey B F, Fraumeni J F. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84: 1422–1427
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te V C, La Vechia C. Non-Hodgkin's lymphoma, chronic lymphocytic leukemias and skin cancers. Br J Cancer 1996; 74: 1847–1850
   PubMed Web of Science ®Google Scholar
• Davidovitz Y, Ballin A, Meytes D. Fluare-up squamous cell carcinoma of skin-following fludarabine therapy for chronic lymphocytic leukemia. Acta Haematol 1997; 98: 44–46
   PubMed Web of Science ®Google Scholar
• Bridges N, Steinberg J J. Aggressive squamous cell carcinoma of the skin after chronic lymphocytic leukemia. J Surg Oncol 1986; 33: 27–30
   PubMed Web of Science ®Google Scholar
• Larsen C R, Hansen P B, Clausen N T. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. Am J Hematol 2002; 70: 48–50
   PubMed Web of Science ®Google Scholar
• Hartley B E, Searle A E, Breach N M, Rhys-Evans P H, Heuk J M. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphoctic leukemia. J Laryngol Otol 1996; 110: 694–695
   PubMed Web of Science ®Google Scholar
• Ziprin P, Smith S, Salerno G, Rosin R D. Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukemia. Br J Dermatol 2000; 142: 525–528
   PubMed Web of Science ®Google Scholar
• Goessling W, McKee P H, Mayer R J. Merkel cell carcinoma. J Clin Oncol 2002; 20: 588–598
   PubMed Web of Science ®Google Scholar
• Robak E, Biernat W, Krykowski E, Jeziorski E, Robak T. Merkel cell carcinoma on chronic lymphocytic leukemia differentiating a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab. Leuk Lymphoma 2005; 46: 909–914
   PubMed Web of Science ®Google Scholar
• Papageorgiou K I, Kaniorou-Larai M G. Case report of Merkel cell carcinoma diagnosis of coexisting lymphadenopthy and indications for early aggressive treatment. BMC Cancer 2005; 5: 106
   PubMed Web of Science ®Google Scholar
• Quaglino D, Di Leonardo G, Lalli G, Pasqualoni E, DiSimone S, Vecchio L, et al. Association between chronic lymphocytic leukemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkel cell) carcinoma. Eur Rev Med Pharmacol Sci 1997; 1: 11–16
   PubMedGoogle Scholar
• Safadi R, Pappo O, Okon E, Sviri S, Eldor A. Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk Lymphoma 1996; 20: 509–511
   PubMed Web of Science ®Google Scholar
• Payne A S, Janes W D, Weiss R B. Dermatologic toxicity of chemotherapeutic agents. Semin Oncol 2006; 33: 86–97
   PubMed Web of Science ®Google Scholar
• Cocuroccia B, Gisondi P, Gubinelli E, Girolomoni G. An itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. Int J Clin Pract 2004; 58: 1177–1179
   PubMed Web of Science ®Google Scholar
• Cohen P R, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin Oncol 1997; 24: 34–59
   Google Scholar
• Kurzrock R, Cohen P R. Vasculitis and cancer. Clin Dermatol 1993; 11: 175–187
   PubMed Web of Science ®Google Scholar
• Youinou P, Mackenzie L E, Lamour A, Mageed R A, Lydyard P M. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur J Clin Invest 1993; 23: 139–150
   PubMed Web of Science ®Google Scholar
• Hamidou M A, El Kouri D, Audrain M, Grolleau J Y. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis 2001; 60: 293–295
   PubMed Web of Science ®Google Scholar
• Wooten M D, Jasin H E. Vasculitis and lymphoproliferative diseases. Semin Arthr Rheum 1996; 26: 564–574
   PubMed Web of Science ®Google Scholar
• Pavlidis N A, Klouvas G, Tsokos M, Bai M, Moutsopoulos H M. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders—a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 1995; 6: 477–482
   Web of Science ®Google Scholar
• Longacre T A, Smoller B R. Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurence in myelodysplastic syndromes. Am J Clin Pathol 1993; 100: 276–284
   PubMed Web of Science ®Google Scholar
• Anhalt G J, Kim S C, Stanley J R, Korman N J, Jabs D A, Kory M, Izumi H, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729–1735
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Amagai M, Watanabe K, Chorzelski T P, Bhogal B S, Black M M, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829–834
   PubMed Web of Science ®Google Scholar
• Hohwy T, Bang K, Steiniche T, Peterslund N A, d'Amore F. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukemic bone marrow infiltration in a case of treatment resistant B-cell chronic lymphocytic leukemia. Eur J Haematol 2004; 73: 206–209
   PubMed Web of Science ®Google Scholar
• Nousari H C, Anhalt G J. Pemphigus and bollous pemphigoid. Lancet 1999; 354: 667–672
   PubMed Web of Science ®Google Scholar
• Horn T D, Anhalt G J. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992; 128: 1091–1095
   PubMed Web of Science ®Google Scholar
• van Mook W NK, Fickers M M, Theunissen P H, Theumissen P HMK, Kley J AMJ, Duijvvestijn J A. Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia. Ann Oncol 2001; 12: 115–118
   PubMed Web of Science ®Google Scholar
• Camisa C, Helm T N, Liu Y C, Valenzuela R, Allen C, Bona S, et al. Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J Am Acad Dermatol 1992; 27: 547–553
   PubMed Web of Science ®Google Scholar
• Braess J, Reich K, Willert S, Strutz F, Neumann C, Hiddemann W, Wormann B. Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL). Ann Hematol 1997; 75: 227–230
   PubMed Web of Science ®Google Scholar
• Gergely L, Varoczy L, Vadsz G, Remenyik E, Illes A. Successful treatment of B-cell chronic lymphocytic leukemia-associated severe paraneoplastic pomphigus with cyclosporin A. Acta Haematol 2003; 109: 202–205
   PubMed Web of Science ®Google Scholar
• Borradori L, Lombardi T, Samson J, Girardet C, Saurat J H, Hugli A. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001; 137: 269–272
   PubMed Web of Science ®Google Scholar
• Hertzberg M S, Schifter M, Sullivan J, Stapleton K. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone. Am J Haematol 2000; 63: 105–106
   Web of Science ®Google Scholar
• Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi M J. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001; 66: 142–144
   PubMed Web of Science ®Google Scholar
• Lapidoth M, David M, Ben Amitai D, Katzenelson V, Lustig S, Sandbank M. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus. Preliminary study. J Am Acad Dermatol 1994; 30: 752–757
   PubMed Web of Science ®Google Scholar
• Williams J V, Marts J G, Billinosley E M. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 2000; 142: 506–508
   PubMed Web of Science ®Google Scholar
• Cuni L J, Grunwald H, Rosner E. Bullous pemphigoid in chronic lympchocytic leukemia with demonstration of antibasement membrane antibodies. Am J Med 1974; 78: 987–992
   Web of Science ®Google Scholar
• Goodnough L T, Muir W A. Bullous pemphigoid as a manifesttion of chronic lymphocytic leukemia. Arch Intern Med 1980; 140: 1526–1527
   PubMed Web of Science ®Google Scholar
• Ameen M, Pembroke A C, Black M M, Russel-Jones R. Eosinophilic spongosis in association with bullous pemphigoid and chronic lymphocytic leukemia. Br J Dermatol 2000; 143: 421–424
   PubMed Web of Science ®Google Scholar
• Aractingi S, Bachmeyer C, Prost C, Caux F, Flaguel B, Fermand J P. Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders. Medicine 1999; 323: 228–235
   Web of Science ®Google Scholar
• Barzilai A, Shapiro D, Golderg I, Ya cob-Hirsch Y, Diaz-Cascajo C, Maytes D, et al. Insect bite-like reaction in patients with hematologic malignant neoplasms. Arch Dermatol 1999; 135: 1503–1507
   PubMed Web of Science ®Google Scholar
• Weed R I. Exaggerated delayed hypersensitivity to mosquito bites in chronic lymphocytic leukemia. Blood 1965; 26: 257–268
   PubMed Web of Science ®Google Scholar
• Kolbusz R V, Micetich K, Armin A R, Massa M C. Exaggerated response to insect bites: an unusual cutaneous manifestation of chronic lymphocytic leukemia. Int J Dermatol 1989; 28: 186–187
   PubMed Web of Science ®Google Scholar
• Pederson J, Carganello J, van der Weyden M B. Exaggerated reaction to insect bites in patients with chronic lymphocytic leukemia. Clinical and histological findings. Pathology 1990; 22: 141–143
   PubMed Web of Science ®Google Scholar
• Dodiuk-Gad R P, Dann E J, Bergman R. Insect bite like reaction associated with mantle cell lymphoma: a report of two cases and review of the literature. Int J Dermatol 2004; 45: 754–758
   Web of Science ®Google Scholar
• Kunitomi A, Konaka Y, Yagata M. Hypersensitivity to mosquito bites as a potential sign of mantle celt lymphoma. Intern Med 2005; 44: 1097–1099
   PubMed Web of Science ®Google Scholar
• Smith K J, Skelton H G, III, Vogel P, Yeager J, Baxter D, Wagner K F. Exaggerated insect bite reactions in patients positive for HIV. J Am Acad Dermatol 1993; 29: 269–272
   PubMed Web of Science ®Google Scholar
• Shibasaki M, Sumazaki R, Takita H. Hypersensitive reactions to mosquito bites in congenital agammaglobulinemia. Ann Allergy 1986; 56: 81–84
   PubMedGoogle Scholar
• Ravandi F, O'Brien S. Infections associated with purine analogs and monoclonal antibodies. Blood Rev 2005; 19: 253–273
   PubMed Web of Science ®Google Scholar
• Morrison V A. The infections complications of chronic lymphocytic leukemia. Semin Oncol 1998; 20: 98–106
   Google Scholar
• Robak T, Kantarjian H, Robertson L, Lerner S, Keating M J. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. Drugs Aging 2005; 25: 983–1012
   Web of Science ®Google Scholar
• Robak T. Monoclonal antibodies in the treatment of chronic lymphoid leukemias. Leuk Lymphoma 2004; 45: 205–219
   PubMed Web of Science ®Google Scholar
• Anaissie E J, Kontoyiannis D P, O'Brien S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998; 129: 559–566
   PubMed Web of Science ®Google Scholar
• Morrison V A, Rai K R, Peterson B L, Kolitz J E, Elias L, Appelbaum F R, et al. Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol 2001; 19: 3611–3621
   PubMed Web of Science ®Google Scholar
• Byrd J C, McGrail L H, Hospenthal D R, Howard R S, Dow N A, Diehl L F. Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study. Br J Haematol 1999; 105: 445
   PubMed Web of Science ®Google Scholar
• Keating M, Coutre S, Rai K, Osterborg A, Faderl S, Kennedy B, et al. Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia. Clin Lymphoma 2004; 4: 220–227
   PubMedGoogle Scholar
• Robak T. Alemtuzumab in the treatment of chronic lymphocytic leukemia. BioDrugs 2005; 19: 9–22
   PubMed Web of Science ®Google Scholar
• Pitini V, Arrigo C, Barresi G. Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab. Br J Haematol 2003; 123: 565
   PubMedGoogle Scholar
• Bikowski J B, Jr. Molluscum contagiosum: the need for physician intervention and new treatment options. Cutis 2004; 73: 202–206
   PubMed Web of Science ®Google Scholar
• Sala M, Font B, Sanfeliu I, Quesada M, Pouts J, Sequra F. Bacillary angiomatosis caused by Bartonella quintana. Ann N Y Acad Sci 2005; 1063: 302–307
   PubMed Web of Science ®Google Scholar
• Mide P, Brunner M, Borchard F, Sudhoff T, Burk M, Zumdick M. Cutaneous bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Arch Dermatol 1995; 131: 933–936
   PubMed Web of Science ®Google Scholar
• Torok L, Viragh S Z, Borka I, Tapai M. Bacillary angiomatosis in a patient with lymphocytic leukemia. Br J Dermatol 1994; 130: 665–668
   PubMed Web of Science ®Google Scholar
• Jewell A P, Giles F J. Cutaneous manifestation of leishmaniasis 40 years after exposure in a patient with chronic lymphocytic leukaemia. Leuk Lymphoma 1996; 21: 347–349
   PubMed Web of Science ®Google Scholar
• Nannini E C, Keating M, Binstock P, Samonis G, Kontoviannis D P. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect 2002; 44: 201–203
   PubMed Web of Science ®Google Scholar
• Smith A G, Jiji R M. Cutaneous infection due to rough variant of Mycobacterium marinum. Am J Clin Pathol 1975; 64: 263–270
   PubMed Web of Science ®Google Scholar